Caliper Life Sciences
Hopkinton, MA 01748
Share:
DxTerity and Caliper Life Sciences Partner to Deliver NEAT® Multiplex Assays on Caliper's LabChip® Dx Platform
- Collaboration Expands Diagnostic Testing, Furthering Personalized Medicine Efforts - Los Angeles, Calif. and Hopkinton, Mass. - DxTerity Diagnostics, Inc. and Caliper Life Sciences, Inc. (NASDAQ: CALP) announced today that the companies have entered into a co-development and co-marketing strategic collaboration that will allow researchers to perform DxTerity's NEAT multiplex diagnostic assays...
Read More »Caliper Introduces the Zephyr® Next Generation Sequencing Post-PCR Workstation
- Adds to the Company's Comprehensive NGS Product Suite which Address Key Bottlenecks in Sample Preparation Workflows - HOPKINTON, Mass., -- Caliper Life Sciences, Inc. (NASDAQ: CALP), a leading provider of tools and services for life science companies, today announced the availability of the Zephyr NGS Post-PCR Workstation. This new Zephyr platform has been specifically designed and...
Read More »Preclinical Imaging System supports in vivo animal imaging.
Integrating optical imaging and low dose microCT, IVIS Spectrum CT enables simultaneous molecular and anatomical longitudinal studies. System provides insights into complex biological systems in small animal models used to develop clinically translatable discoveries. Features include optical sensitivity capable of achieving detection of a few cells and 3D reconstructions of optical molecular...
Read More »Caliper Announces CE IVD Mark for LabChip® Dx for Clinical Patient Sample Testing
- Innovative Microfluidics Technology is now Available for Clinical In Vitro Diagnostic Use in Europe - Hopkinton, MA - Caliper Life Sciences, Inc. (NASDAQ: CALP) announced today that its new, innovative LabChip® Dx instrument has achieved CE IVD registration in Europe. The LabChip Dx, a novel instrument based on Caliper's robust LabChip microfluidics technology, will now be marketed and sold in...
Read More »Roche NimbleGen and Caliper Collaborate to Offer Automated Target Enrichment Pipeline Solution for Next-Generation Sequencing
MADISON, Wisc., and HOPKINTON, Mass., Roche (SIX: RO, ROG; OTCQX: RHHBY) and Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced a co-marketing agreement for the development and optimization of automated protocols for the NimbleGen SeqCap EZ Library solution-based capture method for Caliper's Sciclone-® NGS Workstation. The collaboration aims to simplify high throughput targeted...
Read More »EdgeBio Selects Caliper's Sample Preparation Suite for High Throughput and Benchtop Sequencing Workflows
Caliper and EdgeBio Partner to Automate New Protocols and Sequencing Chemistries HOPKINTON, Mass. and GAITHERSBURG, Md. - Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced a collaboration with Edge BioSystems, Inc., an innovative sequencing service provider based in Gaithersburg, Md. EdgeBio and Caliper will co-develop automated protocols for the 5500xl, SOLiD 4, and Ion Torrent Personal...
Read More »TGAC Selects Caliper Solutions for High Throughput Sequencing Pipeline
- Caliper Automation and Microfluidic Solutions Uniquely Enabling High Throughput Sequencing - HOPKINTON, Mass. - Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced a partnership with The Genome Analysis Centre (TGAC), a leading high throughput sequencing and analysis center based in Norwich, UK establishing TGAC as a National Reference Site. TGAC will implement Caliper's NGS Bundle,...
Read More »Fluorescent Imaging Agent enables personalized medicine research.
Aiding in early detection of disease, XenoLight(TM) RediJect(TM) COX-2 Probe specifically detects cyclooxygenase-2 (COX-2) biomarker noninvasively in live animal models as well as in ex vivo tissue analysis applications. With agent, researchers can also gain understanding of therapeutic efficacy in specific patient populations by monitoring key biomarker response to drug treatment.
Read More »IntegenX Licenses Caliper's Microfluidics Patent Portfolio to Build Apollo 200 RapidHIT(TM) DNA Profiling System
Agreement Enables Commercial Launch into Forensics Markets PLEASANTON, Calif. and HOPKINTON, Mass, - IntegenX Inc. (a privately held corporation) and Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced a license agreement providing IntegenX access to Caliper's microfluidics patent portfolio. IntegenX will leverage its proprietary MOVe(TM) microvalve technology and Caliper's microfluidic...
Read More »Caliper Life Sciences Announces Availability of Automated TruSeq(TM) Next Generation Sequencing Protocols
- Caliper Expands Automated Library Preparation and Target Enrichment Offerings and Highlights Customer Presentations at Advances in Genome Biology and Technology (AGBT) Conference - HOPKINTON, Mass. -- Caliper Life Sciences, Inc. (Nasdaq: CALP) today announced that it has developed and optimized automation protocols on its Sciclone-® NGS Workstation for Illumina's TruSeq(TM) DNA and TruSeq RNA...
Read More »DxTerity and Caliper Life Sciences Partner to Deliver NEAT® Multiplex Assays on Caliper's LabChip® Dx Platform
- Collaboration Expands Diagnostic Testing, Furthering Personalized Medicine Efforts - Los Angeles, Calif. and Hopkinton, Mass. - DxTerity Diagnostics, Inc. and Caliper Life Sciences, Inc. (NASDAQ: CALP) announced today that the companies have entered into a co-development and co-marketing strategic collaboration that will allow researchers to perform DxTerity's NEAT multiplex diagnostic assays...
Read More »Caliper Introduces the Zephyr® Next Generation Sequencing Post-PCR Workstation
- Adds to the Company's Comprehensive NGS Product Suite which Address Key Bottlenecks in Sample Preparation Workflows - HOPKINTON, Mass., -- Caliper Life Sciences, Inc. (NASDAQ: CALP), a leading provider of tools and services for life science companies, today announced the availability of the Zephyr NGS Post-PCR Workstation. This new Zephyr platform has been specifically designed and...
Read More »Preclinical Imaging System supports in vivo animal imaging.
Integrating optical imaging and low dose microCT, IVIS Spectrum CT enables simultaneous molecular and anatomical longitudinal studies. System provides insights into complex biological systems in small animal models used to develop clinically translatable discoveries. Features include optical sensitivity capable of achieving detection of a few cells and 3D reconstructions of optical molecular...
Read More »Caliper Announces CE IVD Mark for LabChip® Dx for Clinical Patient Sample Testing
- Innovative Microfluidics Technology is now Available for Clinical In Vitro Diagnostic Use in Europe - Hopkinton, MA - Caliper Life Sciences, Inc. (NASDAQ: CALP) announced today that its new, innovative LabChip® Dx instrument has achieved CE IVD registration in Europe. The LabChip Dx, a novel instrument based on Caliper's robust LabChip microfluidics technology, will now be marketed and sold in...
Read More »Roche NimbleGen and Caliper Collaborate to Offer Automated Target Enrichment Pipeline Solution for Next-Generation Sequencing
MADISON, Wisc., and HOPKINTON, Mass., Roche (SIX: RO, ROG; OTCQX: RHHBY) and Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced a co-marketing agreement for the development and optimization of automated protocols for the NimbleGen SeqCap EZ Library solution-based capture method for Caliper's Sciclone-® NGS Workstation. The collaboration aims to simplify high throughput targeted...
Read More »EdgeBio Selects Caliper's Sample Preparation Suite for High Throughput and Benchtop Sequencing Workflows
Caliper and EdgeBio Partner to Automate New Protocols and Sequencing Chemistries HOPKINTON, Mass. and GAITHERSBURG, Md. - Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced a collaboration with Edge BioSystems, Inc., an innovative sequencing service provider based in Gaithersburg, Md. EdgeBio and Caliper will co-develop automated protocols for the 5500xl, SOLiD 4, and Ion Torrent Personal...
Read More »TGAC Selects Caliper Solutions for High Throughput Sequencing Pipeline
- Caliper Automation and Microfluidic Solutions Uniquely Enabling High Throughput Sequencing - HOPKINTON, Mass. - Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced a partnership with The Genome Analysis Centre (TGAC), a leading high throughput sequencing and analysis center based in Norwich, UK establishing TGAC as a National Reference Site. TGAC will implement Caliper's NGS Bundle,...
Read More »Caliper Life Sciences to Present at the 36th Annual Deutsche Bank Health Care Conference
HOPKINTON, Mass., April 21, 2011 - Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced that Kevin Hrusovsky, Caliper's President and CEO, will present at the 36th Annual Deutsche Bank Health Care Conference in Boston on May 2, 2011 at 10:40 a.m. ET. A live webcast of the presentation can be accessed at http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=CALP&item_id=3909124 or by...
Read More »Caliper Life Sciences Announces Date and Location of Its 2011 Annual Meeting of Stockholders
HOPKINTON, Mass., April 6, 2011 - Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced that its 2011 Annual Meeting of Stockholders will be held on June 2, 2011, at 10:00 a.m. local time at its offices located at 68 Elm Street, Hopkinton, Massachusetts. The record date for Caliper stockholders entitled to vote at this meeting is April 15, 2011. About Caliper Life Sciences, Caliper Life...
Read More »Caliper Announces New Oncology Research Collaboration
Partners with Denver-based Catholic Health Initiatives to Develop Improved Methods for the Discovery of Cancer Drugs HOPKINTON, Mass., April 5, 2011 - Caliper Life Sciences, Inc. (NASDAQ: CALP), a leading provider of tools and services for drug discovery and life-sciences research, today announced that its Caliper Discovery Alliances and Services (CDAS) unit has formed a research collaboration...
Read More »